N	Concordance
1	 gonadotropin-releasing hormone agonist leuprolide acetate (Lupron), Lupron plus
2	onary embolism.  LHRH  agonists such as leuprolide, goserelin, and buserelin wil
3	ces. A group of patients was treated by leuprolide acetate depot 3 months a year
4	 intranasal nafarelin and intramuscular leuprolide acetate (LA) depot in the man
5	tient was treated with a combination of leuprolide acetate plus flutamide. Four 
6	not occur until after several months of leuprolide treatment, but there was no e
7	ptoms were limited to the luteal phase. Leuprolide was not effective for women w
8	ted in the PMS group but not in the PME leuprolide subjects. Efficacy did not oc
9	ls were consistently higher than in the leuprolide depot group, with significant
10	is often used after orchiectomy or with leuprolide. It has predictable antiandro